{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:54:22Z","timestamp":1794671662756,"version":"4.9.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,9]]},"abstract":"<jats:title>ABSTRACT:<\/jats:title>\n          <jats:p>This Committee Opinion is being revised to provide updated guidance on the management of pregnant women during pregnancy and delivery to prevent mother-to-child transmission of the human immunodeficiency virus (HIV). Prevention of transmission of HIV from the woman to her fetus or newborn is a major goal in the care of pregnant women infected with HIV. Continuing research into mother-to-child transmission of HIV has suggested that a substantial number of cases of perinatal HIV transmission occur as the result of fetal exposure to the virus during labor and delivery. The precise mechanisms are not known. Established and ongoing research has shown that treatment of HIV-infected pregnant women with combined antiretroviral therapy can achieve a 1\u20132% or lower risk of mother-to-child transmission if maternal viral loads of 1,000 copies\/mL or less can be sustained, independent of the route of delivery or duration of ruptured membranes before delivery. Vaginal delivery is appropriate for HIV-infected pregnant women who have been maintained on combined antiretroviral therapy and who have viral loads of 1,000 copies\/mL or less at or near delivery. The risk of mother-to-child transmission in HIV-infected women with high viral loads can be reduced by performing cesarean deliveries before the onset of labor and before rupture of membranes (termed <jats:italic toggle=\"yes\">scheduled cesarean delivery<\/jats:italic> in this document), in conjunction with the use of peripartum maternal antiretroviral therapy. Discussion of the option of scheduled cesarean delivery and its advantages in the situation of suboptimal viral suppression should begin as early as possible in pregnancy with every pregnant woman with HIV infection to give her an adequate opportunity to ask questions and consider her decision-making concerning the delivery plan. The patient's decision regarding her route of delivery should be respected after maternal and neonatal risks have been discussed.<\/jats:p>","DOI":"10.1097\/aog.0000000000002820","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T20:46:13Z","timestamp":1535057173000},"page":"e131-e137","source":"Crossref","is-referenced-by-count":43,"title":["ACOG Committee Opinion No. 751: Labor and Delivery Management of Women With Human Immunodeficiency Virus Infection"],"prefix":"10.1097","volume":"132","member":"276","reference":[{"key":"R1-20230711","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1056\/NEJM199411033311801","article-title":"Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group","volume":"331","author":"Connor","year":"1994","journal-title":"N Engl J Med"},{"key":"R2-20230711","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1056\/NEJM199908053410601","article-title":"Risk factors for perinatal transmission of human immunodeficiency virus type 1 in women treated with zidovudine. Pediatric AIDS Clinical Trials Group Study 185 Team","volume":"341","author":"Mofenson","year":"1999","journal-title":"N Engl J Med"},{"key":"R3-20230711","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1056\/NEJM199908053410602","article-title":"Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. Women and Infants Transmission Study Group","volume":"341","author":"Garcia","year":"1999","journal-title":"N Engl J Med"},{"key":"R4-20230711","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1097\/QAD.0000000000000212","article-title":"Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000\u20132011","volume":"28","author":"Townsend","year":"2014","journal-title":"AIDS"},{"key":"R5-20230711","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/00002030-199802000-00011","article-title":"Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group","volume":"12","author":"Kind","year":"1998","journal-title":"AIDS"},{"key":"R6-20230711","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/jama.280.1.55","article-title":"Perinatal HIV-1 transmission: interaction between zidovudine prophylaxis and mode of delivery in the French Perinatal Cohort","volume":"280","author":"Mandelbrot","year":"1998","journal-title":"JAMA"},{"key":"R7-20230711","first-page":"1035","article-title":"Elective caesarean-section versus vaginal delivery in prevention of vertical HIV-1 transmission: a randomised clinical trial. European Mode of Delivery Collaboration [published erratum appears in Lancet 1999;353:1714]","volume":"353","year":"1999","journal-title":"Lancet"},{"key":"R8-20230711","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199904013401301","article-title":"The mode of delivery and the risk of vertical transmission of human immunodeficiency virus type 1\u2014a meta-analysis of 15 prospective cohort studies. International Perinatal HIV Group","volume":"340","author":"Andiman","year":"1999","journal-title":"N Engl J Med"},{"key":"R9-20230711","doi-asserted-by":"crossref","first-page":"335.e1","DOI":"10.1016\/j.ajog.2013.06.021","article-title":"Cesarean section for HIV-infected women in the combination antiretroviral therapies era, 2000\u20132010","volume":"209","author":"Briand","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"R10-20230711","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/AOG.0000000000002186","article-title":"Delivery after 40 weeks of gestation in pregnant women with well-controlled human immunodeficiency virus","volume":"130","author":"Scott","year":"2017","journal-title":"Obstet Gynecol"},{"key":"R12-20230711","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1097\/01.AOG.0000428648.75548.00","article-title":"Medically indicated late-preterm and early-term deliveries. Committee Opinion No. 560. American College of Obstetricians and Gynecologists","volume":"121","year":"2013","journal-title":"Obstet Gynecol"},{"key":"R13-20230711","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1086\/315152","article-title":"Systemic pharmacokinetics and cellular pharmacology of zidovudine in human immunodeficiency virus type 1-infected women and newborn infants","volume":"180","author":"Rodman","year":"1999","journal-title":"J Infect Dis"},{"key":"R14-20230711","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1093\/cid\/cit374","article-title":"Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? ANRS-EPF CO1-CO11 Study Group","volume":"57","author":"Briand","year":"2013","journal-title":"Clin Infect Dis"},{"key":"R15-20230711","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/hiv.12397","article-title":"HIV viraemia and mother-to-child transmission risk after antiretroviral therapy initiation in pregnancy in Cape Town, South Africa","volume":"18","author":"Myer","year":"2017","journal-title":"HIV Med"},{"key":"R16-20230711","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00002030-200102160-00009","article-title":"Duration of ruptured membranes and vertical transmission of HIV-1: a meta-analysis from 15 prospective cohort studies. International Perinatal HIV Group","volume":"15","year":"2001","journal-title":"AIDS"},{"key":"R17-20230711","doi-asserted-by":"crossref","first-page":"267969","DOI":"10.1155\/2012\/267969","article-title":"HIV mother-to-child transmission, mode of delivery, and duration of rupture of membranes: experience in the current era","volume":"2012","author":"Mark","year":"2012","journal-title":"Infect Dis Obstet Gynecol"},{"key":"R18-20230711","doi-asserted-by":"crossref","first-page":"482.e1","DOI":"10.1016\/j.ajog.2012.10.862","article-title":"Duration of membrane rupture and risk of perinatal transmission of HIV-1 in the era of combination antiretroviral therapy","volume":"207","author":"Cotter","year":"2012","journal-title":"Am J Obstet Gynecol"},{"key":"R19-20230711","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1111\/1471-0528.13442","article-title":"Duration of ruptured membranes and mother-to-child HIV transmission: a prospective population-based surveillance study","volume":"123","author":"Peters","year":"2016","journal-title":"BJOG"},{"key":"R20-20230711","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1097\/QAD.0b013e3282f9b67a","article-title":"Low rates of mother-to-child transmission of HIV following effective pregnancy interventions in the United Kingdom and Ireland, 2000\u20132006","volume":"22","author":"Townsend","year":"2008","journal-title":"AIDS"},{"key":"R21-20230711","doi-asserted-by":"crossref","first-page":"S96","DOI":"10.1016\/j.ajog.2007.02.034","article-title":"Cesarean delivery for HIV-infected women: recommendations and controversies","volume":"197","author":"Jamieson","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R22-20230711","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/0002-9378(83)90963-8","article-title":"Postoperative cesarean section morbidity: a prospective study","volume":"146","author":"Nielsen","year":"1983","journal-title":"Am J Obstet Gynecol"},{"key":"R23-20230711","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/00002030-199508000-00013","article-title":"The incidence of complications after caesarean section in 156 HIV-positive women","volume":"9","author":"Semprini","year":"1995","journal-title":"AIDS"},{"key":"R24-20230711","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1097\/00002030-199607000-00019","article-title":"Fatal complications after Cesarian section in HIV-infected women","volume":"10","author":"Bulterys","year":"1996","journal-title":"AIDS"},{"key":"R25-20230711","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1053\/ob.1996.v175.a75478","article-title":"Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. SEROGEST French Pediatric HIV Infection Study Group","volume":"175","author":"Mandelbrot","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"R26-20230711","first-page":"897","article-title":"Risk factors for perinatal human immunodeficiency virus transmission in patients receiving zidovudine prophylaxis. Pediatric AIDS Clinical Trials Group protocol 076 Study Group","volume":"94","author":"Shapiro","year":"1999","journal-title":"Obstet Gynecol"},{"key":"R27-20230711","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3851\/IMP3075","article-title":"Acute leg ischaemia in an HIV-infected patient receiving antiretroviral treatment","volume":"22","author":"Navarro","year":"2017","journal-title":"Antivir Ther (Lond)"},{"key":"R28-20230711","first-page":"377","article-title":"Update: universal precautions for prevention of transmission of human immunodeficiency virus, hepatitis B virus, and other bloodborne pathogens in health-care settings. Centers for Disease Control (CDC)","volume":"37","year":"1988","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"R29-20230711","doi-asserted-by":"crossref","first-page":"e138","DOI":"10.1097\/AOG.0000000000002825","article-title":"Prenatal and perinatal human immunodeficiency virus testing. ACOG Committee Opinion No. 752. American College of Obstetricians and Gynecologists","volume":"132","year":"2018","journal-title":"Obstet Gynecol"}],"container-title":["Obstetrics &amp; Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00006250-201809000-00069","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T19:55:19Z","timestamp":1689105319000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00006250-201809000-00069"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0000000000002820","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]}}}